Category Archives: Mesenchymal Stem Cells

Leo Olarte, M.D., PMA president. PHOTO from http://www.philippinemedicalassociation.org MANILA, Philippines Politics over stem cell treatment may be behind the move to slap an ethics case against him for allegedly falsifying signatures, the Philippine Medical Association (PMA) president said. In an interview over Inquirer Radio 990 AM on Monday, Dr. Leo Olarte said he found it suspicious that Professional Regulation Commission (PRC) Chair Teresita Manzala announced the ethics case against him on the day of the elections for the next PMA president. He claimed Manzala slapped the ethics case before the PRC to ruin his chances of being re-elected in the countrys largest doctors association. Olarte said Manzala has connections to doctors who are against stem cell medicine. Olarte is a supporter of stem cell treatment. Manzala released the statement on the day of our elections specifically to destroy my name Manzala (also) has connections to doctors who are against stem cell. I am pro-stem cell treatment while my rival (for president) is not, Olarte said in Filipino. In a Philippine Daily Inquirer report on Sunday, Olarte and his four predecessors were charged with fraud in the registration of the Philippine Society for Stem Cell Medicine (PSSCM) in the Securities and … Continue reading →

By: Jet Villa, InterAksyon.com March 17, 2014 7:45 AM FILE PHOTO InterAksyon.com The online news portal of TV5 MANILA - Five doctor-incorporators of the Philippine Society for Stem Cell Medicine (PSSCM) face charges and may have their medical licenses revoked for submitting a fabricated endorsement from the Professional Regulation Commission (PRC) to the Securities and Exchange Commission (SEC). Among them are chairman of the Philippine Medical Association Leo Olarte, PSSCM treasurer and legal counsel; Bu Castro, secretary; Rey Melchor Santos, president; Oscar Tinio, vice president; and Jose Asa Sabili, chairman. In a statement, PRC Chairperson Teresita Manzala on Sunday said she directed the Professional Regulatory Board of Medicine (PRBOM) to initiate, investigate, and file charges against the five doctors before the PRCs legal division for unprofessional, dishonorable, and unethical conduct. Earlier on 10 January 2014, the SEC cancelled the registration of the PSSCM for submitting a fabricated document. In an order signed by SEC Acting Director Ferdinand Sales, the commission said the PSSCM had committed fraud in procuring its Certificate of Incorporation for its application for corporate registration. Wherefore, premises considered, the Certificate of Registration of Philippine Society for Stem Cell Medicine with SEC Registration No. CN201303986, approved on March … Continue reading →

PRC: Stem cell group submitted fake SEC registration. At a press conference in Manila on Monday, March 17, Professional Regulation Commission chairperson Teresita Manzala said the PRC endorsement documents allegedly submitted by the Philippine Society for Stem Cell Medicine (PSSCM) to the Securities and Exchange Commission (SEC) were fabricated and have her tampered signature. The SEC previously revoked the corporate registration of the PSSCM. Danny Pata In a statement, Professional Regulation Commission (PRC) chair Teresita Manzala said she has asked the Professional Regulatory Board of Medicine (PRBOM) to initiate, investigate and file charges against doctors Leo Olarte, Bu Castro, Rey Melchor Santos, Oscar Tinio and Jose Asa Sabili before the PRCs legal division. Olarte is the current president of the PMA. The five doctors are all incorporators of the Philippine Society for Stem Cell Medicine (PSSCM,) which was able to obtain an SEC certificate despite previously being denied corporate registration. They were able to do this, said the statement, by submitting false PRC endorsements to the commission. The PRBOM eventually got hold of a copy of the SEC Registration. On examination of the supposed PRC Endorsement, it was noted that the reference regulatory law used was the Philippine Veterinary Law … Continue reading →

Stem Cell Therapy PRP and Its Success in Treating Older Patients Dr Rodney Dade discusses how regenerative medicine therapies work very well in older patient populations--ages 65 and above in particular--especially the Reg... By: StemCell ARTS … Continue reading →

VIbes-Advanced Stem Cell Therapy PRP Treatment 12 Feb'14 - TV5 Hyderabad By: Vibes Healthcare Ltd … Continue reading →

fat stem cells 2 http://www.arthritistreatmentcenter.com Stem Cells | What about fat? Farshid Guilak and colleagues published an article in the journal Biorheology. In it the... By: Nathan Wei … Continue reading →

Mesenchymal stem cells are those stem cells, in adult tissue, that form a variety of different cell types but are not haematopoietic (blood-forming) stem cells. These non-blood somatic (adult) stem cells are found in the bone marrow, in dental pulp, in skin, and adipose tissue, and are multipotent. Initially thought quite rare in the adult body, these mesenchymal stem cells have now been located in so-called stem cell niches and offer an exciting opportunity for stem cell researchers to investigate their abilities to differentiate into different cell types. The derivation of the term mesenchymal is the mesoderm layer of the embryo itself which differentiates into haematopoietic (blood- and immune-forming) stem cells and mesenchymal stem cells. The mesenchymal stem cells of the mesoderm, in the center of the inner cell mass of the blastocyst, are those which go on to form the internal organs like the liver, and kidneys, along with muscle, connective tissue, and bone. Mesenchymal stem cells do not form blood cells or immune system cells however, despite originating from the same layer of the embryo as the haematopoietic stem cells. The term mesenchymal stem cells is regarded by some as inaccurate and the description of these cells as … Continue reading →

Philadelphia, PA (PRWEB) March 13, 2014 Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of combinatorial biologics for regeneration and disease reversion in human organs and tissues, today announces the appointment of Dr. Luis Martinez, MD, MPH, as VP of Global Operations. We are honored to have someone with Dr. Martinezs experience join us as we execute on a globalized strategy in regenerative medicine, said Ira S. Pastor, CEO, Bioquark Inc. His broad clinical experience in applied regenerative medicine and cellular therapies make him a very valuable addition to the Bioquark team. Dr. Martinez is a regenerative medicine and cell therapy specialist with over 10 years of experience in the clinical setting. He is currently the President of Elite Regenerative Medicine Group, a premier treatment and research center specializing in cell therapy applications for therapeutic, regenerative and preventive purposes. Dr. Martinez obtained his medical degree, as well as his Master of Public Health, at the Ponce School of Medicine and Health Sciences, and completed his residency at the prestigious University of Pennsylvania. He also completed a fellowship in biosecurity with the UPMC Center for Health Security. He is currently a clinical instructor at the Ponce School of Medicine and … Continue reading →

Sarasota, FL (PRWEB) March 12, 2014 Erectile dysfunction (ED) is the most commonly studied disorder when it comes to male sexual dysfunction. It is estimated that 18 million men in the US alone suffer from erectile dysfunction and that it appears to be affecting 1 in 4 males under age 40 according to a study published in The Journal of Sexual Medicine. While the emphasis of treatments for ED focuses on relieving the symptoms, they only provide a temporary solution rather than a cure or reversing the cause. The DaSilva Institute is excited to announce the recruitment of males suffering from ED, in an IRB study, which will look at the safety, and efficacy of autologous, adipose derived stem cells (ADSCs) in regenerating the causes of ED. The evidence shows that ADSCs reverses the pathophysiological changes leading to ED, rather than treating the symptoms of ED. Not only is the data in the literature compelling, but our own, in-house, results on our patients have been phenomenal, states Dr. DaSilva. The many underlying causes for ED that are being investigated range from those secondary to aging, to injury of the cavernous nerve secondary to injury, surgery and/or radiation of the prostate, … Continue reading →

Cell Transplant. Author manuscript; available in PMC Oct 20, 2010. Published in final edited form as: PMCID: PMC2957533 NIHMSID: NIHMS227249 1 Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Shriners Hospitals for Children and Harvard Medical School, 51 Blossom Street, Boston, Massachusetts 02114, USA 2 Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan 3 Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan Corresponding author contact information: Martin L. Yarmush, MD, PhD, Shriners Hospitals for Children, 51 Blossom Street, Boston, MA 02114, Telephone: 617-371-4882; Fax: 617-371-4950; Email: ireis/at/sbi.org *Authors contributed equally Mesenchymal stem cell (MSC) transplantation has been explored as a new clinical approach to repair injured tissue. A growing corpus of studies have highlighted two important aspects of MSC therapy: (1) MSCs can modulate T-cell mediated immunological responses, and (2) systemically administered MSCs home to sites of ischemia or injury. In this review, we describe the known mechanisms of immunomodulation and homing of MSCs. First, we examine the low immunogenicity of MSCs and their antigen presentation capabilities. Next, we discuss the paracrine interactions between MSCs and innate (dendritic cells (DC)) and adaptive immune … Continue reading →